Lhassane Ismaïli

2.0k total citations
76 papers, 1.4k citations indexed

About

Lhassane Ismaïli is a scholar working on Organic Chemistry, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Lhassane Ismaïli has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Organic Chemistry, 43 papers in Pharmacology and 29 papers in Computational Theory and Mathematics. Recurrent topics in Lhassane Ismaïli's work include Cholinesterase and Neurodegenerative Diseases (38 papers), Synthesis and biological activity (32 papers) and Computational Drug Discovery Methods (29 papers). Lhassane Ismaïli is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (38 papers), Synthesis and biological activity (32 papers) and Computational Drug Discovery Methods (29 papers). Lhassane Ismaïli collaborates with scholars based in France, Spain and Tunisia. Lhassane Ismaïli's co-authors include José Marco‐Contelles, Bernard Refouvelet, Mohamed Benchekroun, Vincent Luzet, Hélène Martin, Isabel Iriepa, Marc Pudlo, Fakher Chabchoub, María do Carmo Carreiras and Ignacio Moraleda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lhassane Ismaïli

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lhassane Ismaïli France	22	754	752	510	318	198	76	1.4k
Yong Deng China	26	976 1.3×	831 1.1×	609 1.2×	369 1.2×	438 2.2×	74	1.8k
Rong Sheng China	23	588 0.8×	718 1.0×	390 0.8×	556 1.7×	189 1.0×	103	1.7k
Damijan Knez Slovenia	24	912 1.2×	652 0.9×	698 1.4×	612 1.9×	221 1.1×	74	1.6k
Andrea Milelli Italy	25	796 1.1×	1.0k 1.4×	507 1.0×	902 2.8×	333 1.7×	63	2.2k
Gülberk Uçar Türkiye	30	888 1.2×	1.4k 1.8×	415 0.8×	665 2.1×	152 0.8×	91	2.6k
Bernard Refouvelet France	17	500 0.7×	592 0.8×	294 0.6×	247 0.8×	122 0.6×	48	1.1k
Githa Elizabeth Mathew India	26	704 0.9×	731 1.0×	271 0.5×	443 1.4×	128 0.6×	48	1.7k
Piyoosh Sharma India	19	680 0.9×	411 0.5×	494 1.0×	418 1.3×	340 1.7×	34	1.5k
Angela Stefanachi Italy	23	510 0.7×	834 1.1×	325 0.6×	578 1.8×	77 0.4×	55	1.8k
Sai‐Sai Xie China	25	1.1k 1.5×	764 1.0×	669 1.3×	554 1.7×	401 2.0×	57	2.0k

Countries citing papers authored by Lhassane Ismaïli

Since Specialization

Citations

This map shows the geographic impact of Lhassane Ismaïli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lhassane Ismaïli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lhassane Ismaïli more than expected).

Fields of papers citing papers by Lhassane Ismaïli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lhassane Ismaïli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lhassane Ismaïli. The network helps show where Lhassane Ismaïli may publish in the future.

Co-authorship network of co-authors of Lhassane Ismaïli

This figure shows the co-authorship network connecting the top 25 collaborators of Lhassane Ismaïli. A scholar is included among the top collaborators of Lhassane Ismaïli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lhassane Ismaïli. Lhassane Ismaïli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marco‐Contelles, José, Isabel Iriepa, María do Carmo Carreiras, et al.. (2025). Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer’s Disease. Molecules. 30(19). 3930–3930.

Bernard, Paul J., Maciej Maj, Krzysztof Jóźwiak, et al.. (2024). Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties. Pharmaceutics. 16(1). 121–121. 4 indexed citations

Bernard, Paul J., Lhassane Ismaïli, Thierry Roisnel, et al.. (2024). Synthesis, crystal structures, DFT calculations, and oxygen radical absorbance capacity of 5-arylidene-thiazolidine-2,4‑dione derivatives. Journal of Molecular Structure. 1323. 140672–140672.

Herrero-Labrador, Raquel, Daniel González‐Nieto, Mohamed Benchekroun, et al.. (2023). The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 24(15). 12254–12254. 2 indexed citations

Grosjean, Sylvain, et al.. (2022). Multicomponent Reactions As a Privileged Tool for Multitarget-Directed Ligand Strategies in Alzheimer’s Disease Therapy. Future Medicinal Chemistry. 14(21). 1583–1606. 4 indexed citations

Bernard, Paul J., et al.. (2022). Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties. Molecules. 27(22). 7878–7878. 4 indexed citations

Malek, R.S., Audrey Davis, Maciej Maj, et al.. (2022). Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation. Molecules. 28(1). 71–71. 9 indexed citations

Masmoudi, Fatma, et al.. (2021). Regioselective Synthesis of Novel [1,2,4]Triazolo[1,5‐ a ]pyridine Derivatives. ChemistrySelect. 6(5). 945–950. 3 indexed citations

Chabchoub, Fakher, et al.. (2021). Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2). Bioorganic Chemistry. 116. 105326–105326. 17 indexed citations

10.

Martin, Hélène, Ignacio Moraleda, Alexandre Bonet, et al.. (2020). Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives. International Journal of Molecular Sciences. 21(20). 7652–7652. 13 indexed citations

11.

Carreiras, María do Carmo, Lhassane Ismaïli, & José Marco‐Contelles. (2019). Propargylamine-derived multi-target directed ligands for Alzheimer’s disease therapy. Bioorganic & Medicinal Chemistry Letters. 30(3). 126880–126880. 35 indexed citations

12.

Boulebd, Houssem, et al.. (2018). New highly fluorescent hybrids (benz)imidazol-2-aminonicotinonitrile and -2-aminoisophthalonitrile: synthesis, characterization, fluorescence study, and theoretical calculations. Monatshefte für Chemie - Chemical Monthly. 149(6). 1125–1136. 2 indexed citations

13.

Chioua, Mourad, Ignacio Moraleda, Isabel Iriepa, et al.. (2018). Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease. European Journal of Medicinal Chemistry. 155. 839–846. 43 indexed citations

14.

Martin, Hélène, Alexandre Bonet, Mourad Chioua, et al.. (2017). Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinetriones as Promising Agents for Alzheimer'S Disease Therapy. Future Medicinal Chemistry. 9(8). 715–721. 10 indexed citations

15.

Benchekroun, Mohamed, Alejandro Romero, Javier Egea, et al.. (2016). The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. Journal of Medicinal Chemistry. 59(21). 9967–9973. 89 indexed citations

16.

Ismaïli, Lhassane, Marc Pudlo, Cristóbal de los Rı́os, et al.. (2010). Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists. European Journal of Medicinal Chemistry. 46(1). 1–10. 47 indexed citations

17.

Pertuit, David, Brice Moulari, Thomas Betz, et al.. (2007). 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease. Journal of Controlled Release. 123(3). 211–218. 101 indexed citations

18.

Ismaïli, Lhassane, et al.. (2006). Molecular lipophilicity determination of a huperzine series by HPLC: Comparison of C18 and IAM stationary phases. Journal of Pharmaceutical and Biomedical Analysis. 41(1). 228–232. 13 indexed citations

19.

Ismaïli, Lhassane, Claire André, Laurent Nicod, et al.. (2003). Chromatographic Determination of the Association Constants Between Psoralen Derivatives and Modified β‐Cyclodextrin: Effect of Sucrose as a Co‐enhancer Association Agent. Journal of Liquid Chromatography & Related Technologies. 26(6). 871–882. 6 indexed citations

20.

Guillaume, Yves Claude, Claire André, Nicolas Simon, et al.. (2003). Chromatographic determination of the association constant between 8-methoxypsoralen and modified β-cyclodextrin: protective effect of hydroxypropyl-β-cyclodextrin on 8-methoxypsoralen toxicity in human keratinocytes. Journal of Chromatography B. 798(2). 217–222. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact